6951 - 7000 of 9030 Results
Title
Year
-
OPENTitle: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 88Issue #:Start Page: 156.e11End Page: 156.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7085451Citation Count: 20
-
OPENTitle: Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour DisorderJournal Name: Brain, Behavior, & Immunity - HealthPublisher: Elsevier BVVol: 54Issue #:Start Page: 101257End Page: 101257Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbih.2026.101257Best OA location URL: https://doi.org/10.1016/j.bbih.2026.101257Citation Count: 0
- Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder2020OPENTitle: Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 235End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28318Best OA location URL: http://hdl.handle.net/11380/1227849Citation Count: 17
-
OPENTitle: A common mechanism of singular gene choice is revealed by broadly expressed odorant receptor transgenes within the olfactory epitheliumJournal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 7Start Page: 115955End Page: 115955Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2025.115955Best OA location URL: https://www.cell.com/cell-reports/pdf/S2211-1247(25)00726-0.pdfCitation Count: 3
-
OPENTitle: Identification of risk genes for Alzheimer’s disease by gene embeddingJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 9Start Page: 100162End Page: 100162Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100162Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100162Citation Count: 26
- PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translation2026OPENTitle: PET imaging of alpha-synuclein: from radiotracer design through in vitro and in vivo translationJournal Name: European Journal of Nuclear Medicine and Molecular ImagingPublisher: Springer Science and Business Media LLCVol: 53Issue #: 6Start Page: 4211End Page: 4239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00259-025-07695-0Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13121216/Citation Count: 2
-
OPENTitle: Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for TreatmentJournal Name: Parkinson's DiseasePublisher: WileyVol: 2012Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2012/459321Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/459321.pdfCitation Count: 113
- PTPA variants are rare in early-onset and familial Parkinson’s disease2023RESTRICTEDTitle: PTPA variants are rare in early-onset and familial Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 9End Page: 44Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad244Citation Count: 1
- Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial2019RESTRICTEDTitle: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 145End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8Citation Count: 119
- Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM502024OPENTitle: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50Journal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.99914.3Best OA location URL: https://doi.org/10.7554/elife.99914.3Citation Count: 1
-
OPENTitle: Enhanced Parkinson’s Disease Tremor Severity Classification by Combining Signal Processing with Resampling TechniquesJournal Name: SN Computer SciencePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s42979-021-00953-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s42979-021-00953-6.pdfCitation Count: 25
-
OPENTitle: Post‐Traumatic Shoulder Movement Disorders: A Challenging Differential Diagnosis Between Organic and FunctionalJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 2Start Page: 102End Page: 105Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12016Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4151852Citation Count: 20
-
OPENTitle: Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2018.09.005Citation Count: 28
- Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremor2018RESTRICTEDTitle: Microlesion effects, suboptimal lead placement and disease progression are critical determinants for DBS tolerance in essential tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 129Issue #: 10Start Page: 2215End Page: 2216Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2018.07.024Citation Count: 4
-
OPENTitle: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beadsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.73971Best OA location URL: https://doi.org/10.7554/elife.73971Citation Count: 69
- Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain2018RESTRICTEDTitle: Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brainJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 16Issue #:Start Page: 20End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.11.006Citation Count: 27
-
OPENTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [ 11 C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol: 104Issue #: 4Start Page: 349End Page: 355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
- The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain2019OPENTitle: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrainJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 323Issue #:Start Page: 113062End Page: 113062Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062Citation Count: 19
-
OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page: e12079End Page: e12079Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 215
-
OPENTitle: Deep Learning With EEG Spectrograms in Rapid Eye Movement Behavior DisorderJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 806End Page: 806Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2019.00806Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2019.00806/pdfCitation Count: 115
- The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease2018OPENTitle: The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 171End Page: 176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12591Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12591Citation Count: 64
-
OPENTitle: Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100353End Page: 100353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100353Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100353Citation Count: 3
- Endogenous LRRK2 dimerizes and translocates to novel membrane compartments during monocyte activation2013RESTRICTEDTitle: Endogenous LRRK2 dimerizes and translocates to novel membrane compartments during monocyte activationJournal Name: The FASEB JournalPublisher: WileyVol: 27Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.27.1_supplement.873.17Citation Count: 2
-
RESTRICTEDTitle: Theoretical Optimization of Stimulation Strategies for a Directionally Segmented Deep Brain Stimulation Electrode ArrayJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 2Start Page: 359End Page: 371Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2457873Best OA location URL: http://doi.org/10.1109/TBME.2015.2457873Citation Count: 35
-
OPENTitle: The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domainJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 30Start Page: 14979End Page: 14988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.1900289116Best OA location URL: https://www.pnas.org/content/pnas/116/30/14979.full.pdfCitation Count: 86
-
OPENTitle: Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker‐Defined SynucleinopathyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/acn3.70399Best OA location URL: https://doi.org/10.1002/acn3.70399Citation Count: 1
-
OPENTitle: Classification of pallidal oscillations with increasing parkinsonian severityJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 1Start Page: 209End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00840.2014Best OA location URL: http://doi.org/10.1152/jn.00840.2014Citation Count: 21
-
OPENTitle: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET RadioligandJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 22Start Page: 4210End Page: 4219Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493Best OA location URL: https://doi.org/10.1021/acschemneuro.4c00493Citation Count: 7
-
OPENTitle: Genome-wide association study of neuropathological features in Lewy body diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 8Start Page: 2785End Page: 2796Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaf105Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12316003/Citation Count: 3
-
OPENTitle: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐BerbersJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 4Start Page: 751End Page: 753Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29735Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29735Citation Count: 1
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://doaj.org/article/8d8cf4f9837744e3b7e12b8b5fafeecfCitation Count: 50
-
OPENTitle: Distribution of Parkinson’s disease associated RAB39B in mouse brain tissueJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-020-00584-7Best OA location URL: https://molecularbrain.biomedcentral.com/track/pdf/10.1186/s13041-020-00584-7Citation Count: 12
-
OPENTitle: VPS13D bridges the ER to mitochondria and peroxisomes via MiroJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 220Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202010004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8077184Citation Count: 175
-
OPENTitle: Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterationsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 23Issue #:Start Page: 101856End Page: 101856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101856Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101856Citation Count: 29
-
OPENTitle: Phenotypical variability in the 6-OHDA mouse model of Parkinson's disease despite consistent and robust nigral lesioningJournal Name: Brain MechanismsPublisher: Elsevier BVVol: 148-150Issue #:Start Page: 202523End Page: 202523Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bramec.2025.202523Best OA location URL: https://doi.org/10.1016/j.bramec.2025.202523Citation Count: 1
-
OPENTitle: Five-Year Longitudinal Trajectories of Non-Motor Symptoms in Relation to Baseline Dopaminergic Decline in Parkinson’s DiseaseJournal Name: Brain DisordersPublisher: Elsevier BVVol: 20Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dscb.2025.100288Best OA location URL: https://doi.org/10.1016/j.dscb.2025.100288Citation Count: 0
- Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives2018RESTRICTEDTitle: Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected RelativesJournal Name: Brain TopographyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 6Start Page: 1029End Page: 1036Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10548-018-0653-8Citation Count: 30
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat2015RESTRICTEDTitle: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in ratJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 271Issue #:Start Page: 335End Page: 350Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021Citation Count: 79
-
OPENTitle: LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ciliogenesis blockadeJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 4Issue #: 5Start Page: e202101050End Page: e202101050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202101050Best OA location URL: https://www.life-science-alliance.org/content/lsa/4/5/e202101050.full.pdfCitation Count: 54
-
OPENTitle: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi PanelJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 4Start Page: 652End Page: 657Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13690Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13690Citation Count: 10
- Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindred2019RESTRICTEDTitle: Expert comment to: Novel Xp21.1 deletion associated with unusual features in large McLeod syndrome kindredJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: 133End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.024Citation Count: 2
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 721749End Page: 721749Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://doi.org/10.3389/fnmol.2021.721749Citation Count: 18
-
OPENTitle: Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page: 110End Page: 110Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-025-00896-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-025-00896-zCitation Count: 0
- Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease2020RESTRICTEDTitle: Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson diseaseJournal Name: PsychogeriatricsPublisher: WileyVol: 20Issue #: 6Start Page: 880End Page: 890Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/psyg.12601Citation Count: 20
-
OPENTitle: Polygenic risk scores and Parkinson’s disease in South Africa advancing ancestry informed disease predictionJournal Name: PLOS GeneticsPublisher: Public Library of Science (PLoS)Vol: 22Issue #: 3Start Page: e1012064End Page: e1012064Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1371/journal.pgen.1012064Best OA location URL: https://doi.org/10.1371/journal.pgen.1012064Citation Count: 0
-
OPENTitle: Structure-guided Discovery of Non-catechol Dopamine D1 Receptor Ligands with Biased Agonism and AntagonismJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 302Issue #: 6Start Page: 113076End Page: 113076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jbc.2026.113076Best OA location URL: https://www.jbc.org/article/S0021-9258(26)01948-4/pdfCitation Count: 0
-
OPENTitle: The International Parkinson Disease Genomics Consortium AfricaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 335End Page: 335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00100-9Best OA location URL: http://www.thelancet.com/article/S1474442221001009/pdfCitation Count: 27
-
OPENTitle: Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanismsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 3Start Page: 553End Page: 578Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200937Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/3/553/904049/bcj-2020-0937.pdfCitation Count: 52
- Biomimetic Plasmonic Nanophages by Head/Tail Self-Assembling: Gold Nanoparticle/Virus Interactions2024OPENTitle: Biomimetic Plasmonic Nanophages by Head/Tail Self-Assembling: Gold Nanoparticle/Virus InteractionsJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 18Issue #: 32Start Page: 21302End Page: 21315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsnano.4c05198Best OA location URL: https://durham-repository.worktribe.com/file/2760939/1/Accepted%20Journal%20ArticleCitation Count: 7
-
OPENTitle: Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102600End Page: 102600Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102600Best OA location URL: https://doi.org/10.1016/j.scr.2021.102600Citation Count: 0